Trade Dress Changes May Interfere With Intellectual Property Rights
This article was originally published in The Rose Sheet
Executive Summary
Changes in a product's trade dress as a result of OTC labeling final rule requirements would violate intellectual property protection by restricting product distinctiveness, attorney Charles Buffon, Covington & Burling, asserted at an FDA working group on the OTC reg in Rockville, Md. Aug. 24.
You may also be interested in...
Off-Package Ingredient Labeling Solution For Small Cosmetic-Drugs - CTFA
Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry and Fragrance Association maintained during an agency-industry workshop in Rockville, Md. Sept. 17.
Off-Package Ingredient Labeling Solution For Small Cosmetic-Drugs - CTFA
Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry and Fragrance Association maintained during an agency-industry workshop in Rockville, Md. Sept. 17.
Packaging Color Change Could Decrease Sales 25%, Lauder Tells FDA
Color requirements under FDA's OTC labeling final rule could lead to significant sales losses by negatively affecting brand loyalty and consumer recognition, Origins General Manager Lynn Greene maintained during an OTC labeling workshop in Rockville, Md. Aug. 24.